What is the recommended evaluation and management of bronchiolitis in infants up to 24 months of age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Bronchiolitis in Infants and Young Children

Diagnosis

Bronchiolitis is a clinical diagnosis based solely on history and physical examination—do not order routine chest radiographs, viral testing, or laboratory studies. 1, 2

The diagnosis requires:

  • Age 1-24 months with first episode of wheezing 2
  • Upper respiratory prodrome (2-4 days of rhinorrhea, congestion, low-grade fever) followed by lower respiratory symptoms 2, 3
  • Lower respiratory findings: tachypnea, increased work of breathing (nasal flaring, grunting, intercostal/subcostal retractions), wheezing, and/or crackles 4, 2

When to Consider Chest Radiography

Order chest X-ray only if:

  • Considering intubation 2
  • Unexpected clinical deterioration 2
  • Suspicion of bacterial pneumonia (high fever >38°C, focal findings, tachycardia >100 bpm in context) 5
  • Underlying cardiac or pulmonary disorder 2

Risk Stratification

Immediately identify high-risk infants who require closer monitoring and may progress to severe disease: 1, 2

  • Age <12 weeks (especially <6 weeks) 4, 1
  • Prematurity (<37 weeks gestation, especially <32 weeks) 4, 1
  • Chronic lung disease of prematurity 1, 6
  • Hemodynamically significant congenital heart disease 4, 1
  • Immunodeficiency 1, 2
  • Neuromuscular disease 2, 6

Supportive Care Management

Oxygen Therapy

Administer supplemental oxygen ONLY if SpO₂ persistently falls below 90%, and maintain SpO₂ ≥90%. 1, 3

  • Otherwise healthy infants with SpO₂ ≥90% at sea level gain no benefit from supplemental oxygen 1
  • Discontinue oxygen when: SpO₂ ≥90%, infant feeds well, and minimal respiratory distress present 1
  • Avoid continuous pulse oximetry in stable infants—it leads to less careful clinical monitoring and prolongs hospital stays due to transient desaturations 1
  • Use serial clinical assessments (respiratory rate, work of breathing, feeding ability) rather than continuous monitoring 1

Hydration and Feeding Management

Use this algorithm for feeding decisions based on respiratory rate: 1

If respiratory rate <60 breaths/minute:

  • Continue oral feeding with minimal nasal flaring/retractions 1
  • Continue breastfeeding if possible (reduces hospitalization risk by 72%) 1

If respiratory rate ≥60-70 breaths/minute:

  • Stop oral feeding immediately—aspiration risk increases significantly 1
  • Transition to IV or nasogastric fluids 1, 3
  • Use isotonic fluids specifically because infants with bronchiolitis frequently develop SIADH and are at risk for hyponatremia with hypotonic fluids 1, 2

Airway Clearance

  • Gentle nasal suctioning only as needed for symptomatic relief 1, 6
  • Avoid deep suctioning—associated with longer hospital stays in infants 2-12 months 1
  • Do not use chest physiotherapy—no evidence of benefit 1, 6

What NOT to Do

Pharmacologic Interventions to Avoid

Do not routinely use the following—they lack evidence of benefit: 1, 3

  • Bronchodilators (albuterol, salbutamol): No reduction in hospital admissions or length of stay 1, 7
  • Corticosteroids (systemic or inhaled): Meta-analyses show no significant benefit 1, 6
  • Antibiotics: Use only with specific bacterial coinfection (acute otitis media, documented bacterial pneumonia)—risk of serious bacterial infection is <1% even with fever 1, 5
  • Nebulized hypertonic saline: Not recommended 1, 6
  • Ribavirin: Do not use routinely 1

Common Clinical Pitfalls

  • Do not treat based solely on pulse oximetry readings without clinical correlation—transient desaturations occur in healthy infants 1
  • Do not continue oral feeding based only on adequate SpO₂—an infant may have SpO₂ ≥90% but tachypnea >60-70 breaths/minute making feeding unsafe 1
  • Do not misinterpret radiographic infiltrates as bacterial pneumonia—approximately 25% of hospitalized infants have atelectasis often mistaken for bacterial infection 1
  • Fever alone does not justify antibiotics—serious bacterial infection rate is <1% in febrile infants with bronchiolitis 1

Criteria for Hospitalization

Admit if any of the following are present: 1, 6

  • Persistent SpO₂ <90-92% 6
  • Moderate-to-severe respiratory distress 6
  • Respiratory rate ≥60-70 breaths/minute with inability to maintain oral intake 1
  • Dehydration 6
  • Apnea (especially in infants <6-12 weeks or premature infants) 4, 2
  • High-risk factors requiring closer monitoring 1

Criteria for ICU Transfer

Escalate to intensive care if: 1

  • Worsening respiratory effort despite supplemental oxygen 1
  • Fatigue or exhaustion 1
  • Decreased level of consciousness 1
  • Persistent hypoxemia despite supplemental oxygen 1
  • Respiratory rate ≥70 breaths/minute (correlates with increased risk of severe disease) 4, 1

Prevention Strategies

Environmental Measures

  • Hand hygiene and limiting visitor exposure during RSV season 1, 3
  • Avoid tobacco smoke exposure—significantly increases severity and hospitalization risk 1
  • Keep infants away from crowds and group childcare during RSV season 1

Palivizumab Prophylaxis

Administer monthly during RSV season to: 1, 3

  • Infants born ≤28 weeks gestation during first RSV season in first 12 months of life 1
  • Infants born 29-32 weeks gestation up to 6 months of age 1
  • Infants with chronic lung disease requiring medical therapy within 6 months before RSV season 1
  • Children ≤24 months with hemodynamically significant congenital heart disease 1

Expected Clinical Course

Educate parents that symptoms are expected to last 2-3 weeks—this is normal and does not indicate treatment failure: 1, 2

  • Mean time to cough resolution: 8-15 days 2
  • 90% of children are cough-free by day 21 2
  • Persistent symptoms beyond 4 weeks may represent "post-bronchiolitis syndrome" requiring reassessment 2

References

Guideline

Management of Bronchiolitis in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Bronchiolitis in Young Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Respiratory Syncytial Virus Bronchiolitis in Children.

American family physician, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Distinguishing Bronchopneumonia from Bronchiolitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the current medical understanding and management of bronchiolitis in infants and young children, including definition, classification, etiology, risk factors, epidemiology, pathogenesis, clinical presentation, diagnosis, treatment, and prevention?
What is the diagnosis and management of bronchiolitis in infants and young children?
What is the current information on bronchiolitis, including definition, classification, etiology, risk factors, epidemiology, pathogenesis, clinical presentation, diagnosis, diagnostic criteria, differential diagnosis, treatment, management, prevention, and recommendations for infants and young children?
What is the definition, classification, etiology, risk factors, epidemiology, pathogenesis, clinical presentation, diagnosis, diagnostic criteria, differential diagnosis, treatment, management, prevention, and recommendations for bronchiolitis in infants and young children?
What is the pathophysiology, diagnosis, and management of bronchiolitis in pediatric patients, particularly infants and young children under the age of two?
What is the most appropriate immediate management for a patient with suspected acute pancreatitis?
What oral antibiotic should I prescribe at discharge for a 60-year-old hypertensive diabetic male after umbilical hernioplasty who has received two days of IV ceftriaxone (Monicef 1 g twice daily) and now has fasting glucose 172 mg/dL and blood pressure 140/80 mmHg?
What is the drug of choice for cellulitis in a patient with diabetes mellitus?
What are the differential diagnoses and management plan for an 88‑year‑old woman with new‑onset fecal and urinary incontinence and inability to mobilise?
What is the caloric content of a standard fast‑food cheeseburger?
What is the recommended treatment for a loculated pleural effusion in an adult?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.